1. Toward Gene drive for Vector-Borne Disease Control: A History {#sec1-ijerph-14-01006}
================================================================

1.1. Initial Proposals for Genetic Control of Insect Vectors of Disease {#sec1dot1-ijerph-14-01006}
-----------------------------------------------------------------------

Vector control is critical to the reduction vector-borne diseases \[[@B1-ijerph-14-01006],[@B2-ijerph-14-01006]\]. When mosquitoes were identified as vectors of the pathogens causing diseases such as malaria and yellow fever, efforts were undertaken to eliminate mosquitoes from disease-endemic regions \[[@B3-ijerph-14-01006],[@B4-ijerph-14-01006],[@B5-ijerph-14-01006],[@B6-ijerph-14-01006]\]. Prior to the 1940s, tools to target mosquitoes for elimination were limited to environmental manipulations and non-persistent insecticides. With these tools, successful efforts were made to eliminate both *Anopheles* and *Aedes* species from Cuba, Panama, Brazil and later nearly the entirety of the Americas. \[[@B7-ijerph-14-01006],[@B8-ijerph-14-01006],[@B9-ijerph-14-01006]\]. In 1939 the discovery of DDT (dichloro-diphenyl-trichlorethane) as a persistent insecticide for use against mosquitoes introduced the possibility of sustainable mosquito control and a new objective emerged: global malaria eradication. With this outlook came the impetus to embark on the first global malaria eradication campaign in the 1950s which achieved a remarkable re-drawing of the malaria incidence lines. However, within a decade of its deployment, DDT resistance had emerged alongside social concerns that insecticides caused harm to the environment and human health \[[@B10-ijerph-14-01006],[@B11-ijerph-14-01006]\].

The incredible successes in regional elimination and the ultimate failure to achieve global malaria eradication, provided the context for an interest in genetic approaches to mosquito control. Proposed genetic methods for pest population suppression were inspired by natural genetic phenomena, a trend that continues in the development of molecular tools today. The earliest recognition was made by Serebrovskii, while working with Muller, who realized that X-ray-induced chromosomal translocations caused sterility in offspring heterozygous for the translocation \[[@B12-ijerph-14-01006],[@B13-ijerph-14-01006]\] and by Knipling who, while working for the USDA on the screwworm, *Cochliomya hominvorax*, observed that the agricultural pest was monogamous and males of the species were sexually aggressive \[[@B14-ijerph-14-01006]\]. These observations along with Muller's insect X-ray sterilization procedures, led to a screwworm sterilization program that was the basis of the Sterile Insect Technique (SIT), an approach to pest control that eventually led to the elimination of the screwworm from the entire continent of North America in 1968 \[[@B14-ijerph-14-01006],[@B15-ijerph-14-01006]\]. Concurrently, Vanderplank began work on reducing tsetse fly populations when he recognized that two species (*Glossina morsitans* and *G. swynnertoni*) from different regions could mate, but that the offspring were partly sterile. Releases of each species into the other's regions led to local elimination in both regions \[[@B16-ijerph-14-01006],[@B17-ijerph-14-01006],[@B18-ijerph-14-01006]\].

1.2. Early Definitions and Perspectives on Genetics for Vector Control {#sec1dot2-ijerph-14-01006}
----------------------------------------------------------------------

In 1964, the WHO defined genetic control as "the use of any condition or treatment that can reduce the reproductive potential of noxious forms \[of the insect\] by altering or replacing the hereditary material." This definition encompasses both categories of genetics-based strategies into which today's approaches fall: *population suppression*, which includes strategies to reduce or eliminate an insect population, and *population modification*, which involves replacing existing wild mosquito populations with strains or species that are innocuous in terms of pathogen transmission (also called "replacement" or "alteration") \[[@B19-ijerph-14-01006]\]. Both population suppression and modification in this era were imagined to be manipulations of existing phenotypes and genetic phenomena \[[@B20-ijerph-14-01006],[@B21-ijerph-14-01006]\]. Early proponents of population suppression by genetic means envisioned releasing mosquitoes that would produce sterile offspring after mating with wild mosquitoes, either by cytoplasmic incompatibility or by hybrid sterility as in Vanderplank's tsetse fly experiments. Roles were proposed for genetic elements with interesting inheritance phenotypes, such as sex-ratio distorters that could male-bias a population into extinction. Meiotic drive, a sex-linked genetic component identified in mosquitoes in 1967, showed biased inheritance patterns and was imagined as a mechanism to drive detrimental genes into insect populations \[[@B22-ijerph-14-01006],[@B23-ijerph-14-01006]\].

Enthusiasm was not as high for population modification strategies. Examples of species being replaced by invasion of other insect species gained the strategy special mention in the WHO's 1964 report, but these weren't characterized thoroughly enough to inspire confidence in intentionally affecting the replacement of vector mosquitoes with innocuous strains or species. However, Wood et al. showed in 1977 that a gene could be driven into an *Aedes aegypti* cage population using negative heterosis/underdominance, a phenomenon whereby reduced survival of heterozygotes allowed a skewing of the population toward released mosquitoes \[[@B24-ijerph-14-01006],[@B25-ijerph-14-01006],[@B26-ijerph-14-01006]\]. These demonstrations along with investigations into the biological basis of mosquito refractoriness to vector-transmitted pathogens stimulated renewed enthusiasm for population modification strategies \[[@B23-ijerph-14-01006],[@B27-ijerph-14-01006],[@B28-ijerph-14-01006]\].

1.3. The Birth (or Coming-of-Age) of a New Field: Vector Biology Leverages Natural Genetic Phenomena to Develop Important Tools in Mosquito Genetics {#sec1dot3-ijerph-14-01006}
----------------------------------------------------------------------------------------------------------------------------------------------------

A range of possibilities for genetics-based vector control was documented in these early studies, but much had yet to be done. The field of vector-borne disease research was not highly populated or well-funded. By the 1980s vector-borne diseases were re-emerging into previously controlled or non-endemic areas and there was still a lack of vaccines and therapeutics for many of these diseases. Studies in vector biology and the development of genetics-based tools for vector control were seen as a mostly untapped, but critical potential source of new disease-control strategies. In response to the stagnancy in vector work, a group of scientists proposed to stimulate the field by integrating researchers with relevant, but disparate expertise into vector biology and by moving technology that had been introduced in other genetic systems into vector biology. Thus the Vector Biology Network (VBN) was formed, the activities of whom led to a remarkable growth in genetic technologies for mosquitoes and primed the field for the application of modern genetic manipulation to the problem of vector-borne diseases \[[@B29-ijerph-14-01006]\]. Following the establishment of the VBN, a boom in funded research and scientific reports reflected the rapidly growing knowledge in vector molecular biology and genetics \[[@B29-ijerph-14-01006]\].

The introduction of new advances in biotechnology to the field of vector biology was predicted to lead to new approaches to vector control. Indeed, an entire genre of synthetic mechanisms, including a vision for gene drive systems were developed, inspired by the discovery and characterization of naturally-occurring selfish genetic elements \[[@B30-ijerph-14-01006],[@B31-ijerph-14-01006],[@B32-ijerph-14-01006],[@B33-ijerph-14-01006]\]. These that are inherited more frequently than expected by Mendelian inheritance patterns and so have the potential to overcome evolutionary constraints and spread desired genotypes into vector populations either for suppression or modification strategies. The last half of the 20th century would see many developments based on selfish genetic elements \[[@B34-ijerph-14-01006]\].

### 1.3.1. Transposons as a Basis for Genetic Transformation {#sec1dot3dot1-ijerph-14-01006}

In the 1950s, McClintock's work revealed that genes called transposons could mobilize within a genome \[[@B35-ijerph-14-01006]\]. We now understand that some transposons can spread quite rapidly through populations despite severe costs to the host \[[@B36-ijerph-14-01006],[@B37-ijerph-14-01006],[@B38-ijerph-14-01006],[@B39-ijerph-14-01006]\]. This finding was key to insect transformation, which was initially achieved using the *P*-element in *Drosophila melanogaster* \[[@B40-ijerph-14-01006]\]. Non-drosophilid insects were more difficult to transform as the *P*-element wasn't active in other insects, few visible markers to screen for transformants were available, and many insect-rearing requirements were less straight-forward than for drosophilids \[[@B41-ijerph-14-01006]\]. By 2002, transformation of several mosquito species was achieved using transposons identified as active in mosquitoes: *Hermes* elements in *Aedes aegypti* (1998) and *Culex quinquefasciatus* (2001), a mos1/mariner element in *Ae. aegypti* (1998), and the *piggyBac* element in *Anopheles stephensi* (1999), *An. gambiae* (2000), *Cx. quinquefasciatus (2001) An. albimanus* (2002), *Ae. fluviatilis* (2006) and *Ae. albopictus* (2010) \[[@B42-ijerph-14-01006],[@B43-ijerph-14-01006],[@B44-ijerph-14-01006],[@B45-ijerph-14-01006],[@B46-ijerph-14-01006],[@B47-ijerph-14-01006],[@B48-ijerph-14-01006],[@B49-ijerph-14-01006],[@B50-ijerph-14-01006]\]. New transformations in mosquitoes were complimented by continued description of useful promoters and gene control elements, the advancement of sequencing technology, and the application of fluorescent markers, without which most transposon insertions would be undetectable (for a comprehensive promoter list see Table 8.2 in \[[@B51-ijerph-14-01006]\]). It was imagined that transposons would also be useful as a gene drive system, but transposons that could mediate insertion into a mosquito's genome were not so easily remobilized \[[@B52-ijerph-14-01006],[@B53-ijerph-14-01006],[@B54-ijerph-14-01006],[@B55-ijerph-14-01006],[@B56-ijerph-14-01006],[@B57-ijerph-14-01006]\]. Only recently has a synthetic construct based on the *piggyBac* transposon been demonstrated to mobilize itself once inserted into a mosquito genome, but rarely \[[@B58-ijerph-14-01006],[@B59-ijerph-14-01006]\].

### 1.3.2. The Skewing of a Population toward Desirable Genotypes Using Underdominance and Cytoplasmic Incompatibility {#sec1dot3dot2-ijerph-14-01006}

Underdominance was described in early papers as negative heterosis, the phenomenon of heterozygotes being less fit than homozygotes; it was proposed that a target population could be modified if genetic components that caused negative heterosis were linked with a desirable trait and introduced at a high enough proportion. After much of the resulting population was diminished (all heterozygotes), the allele highest in abundance would increase to fixation \[[@B20-ijerph-14-01006]\]. Curtis explored this in the lab and in the field using translocations \[[@B24-ijerph-14-01006],[@B28-ijerph-14-01006]\]. A synthetic design where underdominance is encoded as two separate gene constructs, both linked to the effector gene to be driven, was proposed by Davis et al. in 2001 and successfully developed into a *Drosophila* gene drive strain by Akbari et al. in 2013, but has not yet been demonstrated in mosquitoes \[[@B60-ijerph-14-01006],[@B61-ijerph-14-01006]\]. Cytoplasmic incompatibility can similarly drive the fixation of a genotype of a released strain by reducing the survival of offspring from parents with differing *Wolbachia* infection status \[[@B62-ijerph-14-01006],[@B63-ijerph-14-01006],[@B64-ijerph-14-01006]\], and was proposed to be recapitulated using *Wolbachia* genes in transformed mosquitoes, but these have only recently been identified using comparative genomics of *Wolbachia* strains in *Drosophila* \[[@B65-ijerph-14-01006],[@B66-ijerph-14-01006],[@B67-ijerph-14-01006]\]. Transformation of *D. melanogaster* with these genes produced cytoplasmic incompatibility phenotypes; it is possible that this strategy will be feasible in mosquitoes in the near future \[[@B65-ijerph-14-01006]\].

### 1.3.3. The Application of Naturally Occurring Selfish Elements to Synthetic Gene drives in Mosquitoes {#sec1dot3dot3-ijerph-14-01006}

Naturally occurring selfish elements called Maternal Effect Dominant Embryonic Arrest (MEDEA) were discovered to spread through populations of the flour beetle, *Tribolium castaneum,* by segregation distortion, favoring offspring that encode the element \[[@B68-ijerph-14-01006],[@B69-ijerph-14-01006]\]. In this insect, a single MEDEA locus was described to bear genes encoding both a maternal product that is lethal to developing embryos and a zygotic product that rescues offspring from the lethal product, so that only progeny bearing the locus would survive to adulthood; this system inspired engineering of the first successful demonstration of a synthetic gene drive \[[@B70-ijerph-14-01006]\].

Mobile introns were described in the 1970s in yeast that were capable of "homing"; they could be copied laterally to a homologous sequence and so increase their presence in offspring \[[@B71-ijerph-14-01006],[@B72-ijerph-14-01006],[@B73-ijerph-14-01006]\]. Site-specificity was attributed to endonuclease recognition of DNA sequence \[[@B74-ijerph-14-01006]\]. These elements called homing endonuclease genes (HEGs) are widespread and demonstrate the non-Mendelian inheritance that is attractive for vector control applications. In 2003, HEGs were proposed as a useful basis for gene drive \[[@B75-ijerph-14-01006]\] and work was already underway to modify the endonucleases to recognize specific insect sequences \[[@B76-ijerph-14-01006],[@B77-ijerph-14-01006],[@B78-ijerph-14-01006]\]. Successful engineering of a HEG-based gene drive in *An. gambiae* was reported in 2011 \[[@B79-ijerph-14-01006]\].

### 1.3.4. The Application of the Endosymbiont *Wolbachia* to Gene drive in Mosquitoes {#sec1dot3dot4-ijerph-14-01006}

The bacterial endosymbiont *Wolbachia pipentis* was identified as the cause of reproductive phenotypes described as early as 1967 that bias inheritance of the bacteria in crosses between infected and uninfected mosquitoes \[[@B62-ijerph-14-01006],[@B63-ijerph-14-01006],[@B64-ijerph-14-01006],[@B80-ijerph-14-01006]\]. The bacteria's reproductive phenotypes can lead to their spread into an insect population. *Wolbachia* has thus been proposed as a driver for a synthetic gene construct, but thus far the bacteria have not been amenable to transformation \[[@B67-ijerph-14-01006],[@B81-ijerph-14-01006],[@B82-ijerph-14-01006],[@B83-ijerph-14-01006]\]. However, the reproductive phenotypes of the endosymbiont have provided useful strategies to combat mosquito-borne disease, both for mosquito population suppression and modification. The *w*Pip strain of *Wolbachia* isolated from *Cx. pipiens Linnaeus* has been used to infect *Ae. albopictus* and infected males are being used in a strategy analogous to SIT. The strategy is based on the observation that *w*Pip infected males mate with and sterilize wild females, which are naturally infected with other strains of *Wolbachia* \[[@B80-ijerph-14-01006],[@B84-ijerph-14-01006],[@B85-ijerph-14-01006],[@B86-ijerph-14-01006],[@B87-ijerph-14-01006],[@B88-ijerph-14-01006]\]. *Wolbachia*'s drive potential paired with the discovery that the *Wolbachia* strain *w*Mel can block the development of dengue in *Ae. aegypti* and thereby interrupt transmission of the virus has led to a population modification strategy based on a combination of pathogen-blocking and gene drive. Releases of *Wolbachia*-infected mosquitoes in Australia, Vietnam, Colombia and Brazil have been some of the most widespread and effective examples of population modification in wild vector populations \[[@B89-ijerph-14-01006],[@B90-ijerph-14-01006],[@B91-ijerph-14-01006],[@B92-ijerph-14-01006]\].

The *Wolbachia*-based programs have, in some ways, benefited from drive elements already crafted in nature to be effective. Still, a good amount of human ingenuity goes into discovery, description and assessment of the mosquito phenotypes and drive characteristics, and some engineering can be required for successful application. An additional advantage of these platforms is that release of mosquitoes carrying *Wolbachia* is perceived as a biocontrol agent and regulated as a microbial biopesticide, similar to *Bacillus thuringiensis* (Bt), since it already exists in nature, infecting 52% of the world's arthropods \[[@B93-ijerph-14-01006]\], rather than as a genetic-drive system which would face heightened regulations. *Wolbachia*-based strategies have not been categorized in a regulatory sense as genetic modification, which has offered some benefits in terms of implementation, but categorization of *Wolbachia* as a biopesticide is not always an advantage. Surveys of communities in Australia, probed before application of *Wolbachia,* showed that communities can be sensitive to the risks of "biocontrol" citing a number of locally known cautionary tales \[[@B94-ijerph-14-01006]\]. Distinction of applications of *Wolbachia* as a biopesticide as opposed to a genetic mechanism and specifically a gene drive is not precise, since *Wolbachia* does drive a set of genes into mosquito populations (the entire bacterial genome) that was previously foreign, the endosymbiont is maternally inherited and integrations of *Wolbachia* genes have been identified in many *Wolbachia* host species (including *Ae. aegypti*) which is perhaps not surprising given that the bacterial genome is heavily occupied by repeats and transposable elements, \[[@B95-ijerph-14-01006],[@B96-ijerph-14-01006],[@B97-ijerph-14-01006],[@B98-ijerph-14-01006],[@B99-ijerph-14-01006],[@B100-ijerph-14-01006],[@B101-ijerph-14-01006],[@B102-ijerph-14-01006]\].

1.4. Synthetic Approaches to Genetic Strategies for Mosquito Control {#sec1dot4-ijerph-14-01006}
--------------------------------------------------------------------

Synthetic genetic technologies have a number of advantages over technologies employing only existing biological systems. The components of a synthetic construct are relatively small, their functions are more fully known and the site in the mosquito genome where they are located can be characterized, such that modifying the pathogen-targeting or mosquito suppression genes could be relatively straight-forward. It follows, then, that the effectiveness of a defined set of synthetic genes could be more accurately assessed for aspects that need improvement, and improvements more easily engineered. In contrast, the biology around dengue resistance and cytoplasmic incompatibility phenotypes incurred by *Wolbachia* infection are largely unknown; this paired with our current inability to transform the endosymbiont means that we cannot currently adjust the approach at the genetic level. A given genetic strategy requires an effector gene or a set of genes to encode population suppression or pathogen-blocking genotypes and a method to detect whether a mosquito bears the effector genotype (e.g., a marker). Modular designs for genetic constructs allow the combination of promotors, effectors and markers that can encode a set of gene modules that can execute a very specific purpose into a single genetic package. These designs are straight-forward to construct once appropriate genetic elements exist and are characterized for each module.

### 1.4.1. The "Flightless Female": An Illustration of a Fully Realized Population Suppression Strategy Using Synthetic Gene Modules {#sec1dot4dot1-ijerph-14-01006}

Genetic engineering of synthetic phenotypes has led to the development of population-suppression strains of mosquitoes, the most successful so far is known as the "flightless female" *Ae. aegypti*. This strain contains a genetic element that encodes a toxin to destroy the wing muscles of females. Without normal function in wing muscles, the females are unable to mate or search for food and oviposition sites. The transgene construct responsible for this phenotype encodes a repressible, late-acting, sex-specific lethal, allowing rearing and sexing prior to release as well as survival of larvae in subadult stages to compete with wild larvae \[[@B103-ijerph-14-01006],[@B104-ijerph-14-01006],[@B105-ijerph-14-01006],[@B106-ijerph-14-01006]\]. The gene set that encodes these phenotypes is spread into the population by male carriers who are unaffected by the transgene. Males are being released as a control strategy in Brazil and Florida after large cage trials validated their usefulness for population suppression \[[@B107-ijerph-14-01006],[@B108-ijerph-14-01006]\]. Similar strains have been developed in *Ae. albopictus* and *An. stephensi*, but have not yet been utilized to control wild populations \[[@B109-ijerph-14-01006],[@B110-ijerph-14-01006]\]. These strains offer a population suppression strategy in species where no SIT or SIT-like strategy has yet been successful.

The combination of gene modules used to generate this line illustrate the utility of a synthetic construct in encoding marker and effector genes with expression characteristics that serve a specific genetic mosquito control strategy. An accounting of the requirements for the control strategy dictates the modules needed. *A lethal phenotype:* the effector gene *VP16* causes cell toxicity \[[@B111-ijerph-14-01006],[@B112-ijerph-14-01006]\]. *Female specificity:* ideally, the lethal gene would affect females and not males, since females transmit pathogens and males can be carriers of the genes to wild populations. A female specific promoter, *AeActin4*, is not expressed in males, but drives expression of VP16 in the female flight muscles. *Repressibility of lethality for rearing*: viable females are needed, so the construct was designed to be repress *VP16* expression using tetracycline, in which the mosquitoes can be reared in the lab, but since they aren't exposed to tetracycline in the wild, the effector will be turned on in wild offspring of transgenic mosquitoes. *Identification:* To distinguish between transgenic and wild-type mosquitoes, a gene for the fluorescent marker, *DsRed*, is encoded on the construct and expressed in the eyes of the mosquito. Each of the components of this system stems from previously identified characteristics in insect biology, combined intelligently to achieve a very specific purpose. One would be hard-pressed to identify a naturally occurring biological system that meets all of these requirements. It's important to note here that the more we understand about mosquito biology and the biology of other insects, the more power we have to design a construct that most serves a given purpose. This brings us to the benefit of being able to specifically study genetic systems in mosquitoes; molecular tools to study basic biology are needed to support the applied science of elimination and eradication of vector-borne disease.

### 1.4.2. Synthetic Engineering for Complete Pathogen Blocking {#sec1dot4dot2-ijerph-14-01006}

Selection for mosquitoes that are resistant to human pathogens was recognized early on as a disease control strategy that would take advantage of genes already in mosquitoes \[[@B23-ijerph-14-01006],[@B27-ijerph-14-01006]\]. Some candidate genes and pathways have been identified in *An. stephensi, An. gambiae* and *Ae. aegypti* as potential candidates for such efforts \[[@B113-ijerph-14-01006],[@B114-ijerph-14-01006],[@B115-ijerph-14-01006],[@B116-ijerph-14-01006],[@B117-ijerph-14-01006],[@B118-ijerph-14-01006],[@B119-ijerph-14-01006],[@B120-ijerph-14-01006],[@B121-ijerph-14-01006],[@B122-ijerph-14-01006],[@B123-ijerph-14-01006],[@B124-ijerph-14-01006],[@B125-ijerph-14-01006],[@B126-ijerph-14-01006]\]. For example, perturbations of AKT signaling and transgene-mediated expression of the IMD signaling gene Rel2 have both been demonstrated to increase the ability of *An. stephensi* to kill *P. falciparum* \[[@B114-ijerph-14-01006],[@B127-ijerph-14-01006],[@B128-ijerph-14-01006],[@B129-ijerph-14-01006],[@B130-ijerph-14-01006]\]. Increased dengue resistance was demonstrated in *Ae. aegypti* with silencing of vATPase and IMDPH expression \[[@B117-ijerph-14-01006]\]. Some synthetic genes constructs have been successful in conferring pathogen-resistant phenotypes. The first demonstration of a stably-integrated synthetic construct that produced an anti-pathogen product in mosquitoes was reported in 2002 with the generation of a transgenic *An. gambiae* line expressing a peptide that bound to *P. berghei* \[[@B130-ijerph-14-01006]\]. Other constructs have since been developed in both *Anopheles* and *Aedes* species with increasing levels of pathogen resistance (for a comprehensive list see Table 13.2 in \[[@B131-ijerph-14-01006]\]), including lines in both *An. stephensi* and *Ae. aegypti* that completely eliminated pathogen presence in the salivary glands, the tissue it must reach to be transmitted to humans \[[@B132-ijerph-14-01006],[@B133-ijerph-14-01006]\]. In these synthetic cases, defined biological components are combined in a way that meets a specified goal: promoters specific to that species and expressed locally and temporally consistent with pathogen exposure, gene products that inhibit a pathogen, and a visual marker of the transgene.

1.5. A Technology-Driving Need for Site-Specific Gene Editing {#sec1dot5-ijerph-14-01006}
-------------------------------------------------------------

Technological improvements in mosquito genetics in the 20th century and into the following decade had yet to sufficiently address an important gap: we still lacked the ability to target a specific site on a mosquito genome either for probing biological functions, for the targeted insertion of a synthetic construct, or for a gene drive. While transposons were successful platforms for transformation, their short target sites allow them to insert into many locations in the genome \[[@B134-ijerph-14-01006],[@B135-ijerph-14-01006]\]. For the construction of transgenic lines, this means that the site in which a synthetic construct is inserted could cause a fitness reduction in a transgenic line, depending on where they insert \[[@B136-ijerph-14-01006],[@B137-ijerph-14-01006],[@B138-ijerph-14-01006],[@B139-ijerph-14-01006]\]. For gene drive based on the mobility of transposons, it means that the drive would likely incur a fitness cost as a result of continued re-mobilization into new sites in a genome. The mechanism of HEGs for gene drive were based on site-specific engineering, accomplished by target recognition and endonuclease functions of a HEG, but engineering a HEG to target a specific nucleotide sequence is not straight-forward \[[@B140-ijerph-14-01006]\]. The successful targeting of a HEG to a mosquito locus was reported in 2007 \[[@B141-ijerph-14-01006]\] and a HEG-based gene drive was reported in 2011, almost a decade after they were proposed as a basis for a gene drive mechanism \[[@B79-ijerph-14-01006]\]. The application of ϕC31 to mosquitoes improved our ability to move constructs into known locations in the genome, but these "docking sites" were pre-established in transgenic lines by random transposon-mediated integration, so specific genes could not be targeted for modification ([Table 1](#ijerph-14-01006-t001){ref-type="table"}) \[[@B50-ijerph-14-01006],[@B132-ijerph-14-01006],[@B142-ijerph-14-01006],[@B143-ijerph-14-01006]\].

The application of zinc-finger nucleases (ZFNs) to gene targeting introduced a major improvement to genetic studies in mosquitoes. Zinc-finger domains recognize the shapes of nucleotide triplets in the major groove of a DNA double-helix and could be engineered to recognize a 18 nucleotide sequence such that a whole array of protein effectors could be recruited to a very specific site in the genome \[[@B144-ijerph-14-01006],[@B145-ijerph-14-01006],[@B146-ijerph-14-01006]\]. Zinc-finger domains are conjugated to a FokI type II restriction endonuclease and created in pairs recognizing sequences flanking a target-site so that a pair of ZFNs would create a double-stranded break at a specific genomic locus \[[@B146-ijerph-14-01006],[@B147-ijerph-14-01006]\]. These improvements meant that engineering target-site recognition with ZFNs was modular and more-straight forward than for HEGs. However, the cost of a ZFN and the low success rate was still prohibitive to the technology being used by most labs for biological studies. Finally, in 2010, a system that was affordable and could be engineered in-house, made targeted mutagenesis accessible for molecular biology labs: transcription activator-like effector (TALE) nucleases or TALENs. Like ZFNs, TALENs are modular, could be encoded on a plasmid by cloning and were relatively efficient \[[@B148-ijerph-14-01006]\]. The recognition of each nucleotide on a DNA target was encoded in the 12th and 13th amino acid of each 34 amino-acid repeat; a peptide stretch of 18 or 19 repeats could be engineered to recognize any nucleotide sequence and when conjugated to the FokI domain and could induce site-specific DNA cleavage \[[@B149-ijerph-14-01006],[@B150-ijerph-14-01006]\]. While 18--19 repeats in the TAL portion of protein initially made cloning difficult, kits were soon developed to do this easily and by 2013 a library of TALENs existed for targeting 18,740 human protein coding genes \[[@B151-ijerph-14-01006]\]. Gene-editing in *Ae. aegypti* and *An. stephensi* using ZFNs and TALENs were reported in 2013 \[[@B152-ijerph-14-01006],[@B153-ijerph-14-01006],[@B154-ijerph-14-01006]\]. With increased efficiency, an order of magnitude difference in price, and less difficulty in constructing TALENs in the lab, TALENs were more accessible than previous gene-editing approaches. But the timing of TALEN development was almost concurrent with the leveraging of CRISPR/Cas9 biology for gene-editing, meaning that TALENs usefulness was short-lived.

Within the 2003 proposal to utilize HEGs as platforms for gene drive, Burt highlighted the condition that would bring ease and efficiency to site-specific engineering; the homing mechanism of group II introns is specific DNA targeting by Watson-Crick base-pairing, which is straightforward to reprogram, instead of by a specific protein shape, as is needed for HEGs, ZFNs and TALENS \[[@B75-ijerph-14-01006],[@B155-ijerph-14-01006]\]. Group II introns were not pursued for gene drive because of other limiting complexities, but the bacterial CRISPR-Cas systems that also use base-paring for DNA recognition were harnessed for site-specific gene-editing, providing by far the most-successful basis for the development of synthetic gene drive systems to date.

2. What Cas9 Has Done for Synthetic Genetic Engineering and Gene drive {#sec2-ijerph-14-01006}
======================================================================

Shortly after Cas9-mediated gene-editing was introduced in 2012 \[[@B156-ijerph-14-01006]\], and first demonstrated in human and mouse cells in 2013 \[[@B157-ijerph-14-01006],[@B158-ijerph-14-01006]\], the technique was applied to mosquitoes to create specific gene-mutant *Ae. aegypti* lines in 2015 \[[@B159-ijerph-14-01006],[@B160-ijerph-14-01006],[@B161-ijerph-14-01006],[@B162-ijerph-14-01006]\]. In the same year Cas9 was used to develop the first efficient insect gene drives in *D. melanogaster, An. stephensi* and *An. gambiae* \[[@B163-ijerph-14-01006],[@B164-ijerph-14-01006],[@B165-ijerph-14-01006]\]. Since 2015 we have also seen an expansion in the number of mosquito species to be genetically modified to include *An. funestus*, which did not have transgenic technologies available before the introduction of Cas9-mediated editing \[[@B166-ijerph-14-01006]\]. The reader will appreciate how quickly these applications arose following the introduction of CRISPR/Cas system to genetics, given the history in genetics advancement reviewed thus far ([Table 1](#ijerph-14-01006-t001){ref-type="table"}).

Cas9 is an endonuclease borrowed from the CRISPR biology of the bacteria *Streptococcus pyogenes*. CRISPR stands for "Clustered Regularly Interspersed Palindromic Repeats" and refers to the loci that are widespread in bacterial and archaeal genomes that store sequences of parasitic nucleic acid to which they were previously exposed \[[@B167-ijerph-14-01006],[@B168-ijerph-14-01006],[@B169-ijerph-14-01006],[@B170-ijerph-14-01006],[@B171-ijerph-14-01006]\]. These are co-located on the bacterial genome with *Cas* (CRISPR associated) genes which are expressed and used to target and destroy incoming parasites with homology to small RNAs derived from the CRISPR loci. Cas9 endonucleases can be targeted to virtually any region of a genome by encoding a homologous \~20 nucleotides on a modified single guide RNA (sgRNA), which will localize Cas9 to the target site for double-stranded cleavage of the DNA \[[@B156-ijerph-14-01006]\].

The application of Cas9 to gene editing in mosquitoes has made mosquito gene-editing cheaper, more targeted and more efficient. Cas9-nuclease targets a specific location using a sgRNA which is easily programmed using a \$20 oligonucleotide. The Cas9 protein can be ordered or made in-house (\<\$200 for bottle large enough to inject \>10,000 embryos) and mixed with in vitro transcribed sgRNAs targeting a desired genomic locus. This is an improvement over TALENs and ZFNs, which required novel protein engineering for each target. Cas9/sgRNA complexes are delivered to insects by embryo injection (these embryos represent the Generation (G) 0); for *Ae. aegypti*, this has resulted in gene-specific mutation efficiency as high as 90% in G~1~ offspring \[[@B172-ijerph-14-01006]\]. However, mutations with non-visible phenotypes are not easily detected and maintained without the insertion of a marker. This can be achieved by co-injection of a donor plasmid that encodes a marker (e.g., fluorescence in the eyes or body) between regions of homology flanking the sgRNA target site.

The donor provides a template for the mosquito cells to repair the Cas9-induced double-stranded break by homology-directed repair (HDR) instead of non-homologous end joining (NHEJ). Initial attempts at Cas9-mediated transformation of *Ae. aegypti* demonstrated efficiencies 0.1--0.4% of injected G~0~ embryos \[[@B161-ijerph-14-01006]\]. This efficiency is lower in *Anopheles* species. Cas9-mediated transformation is less than 0.01% in *An. stephensi* and in *An. gambiae,* pre-establishment of transgenic lines expressing Cas9 and sgRNAs are generally required for transformation \[[@B164-ijerph-14-01006]\] (Andrea Smidler personal communication). Improvement has been made with the demonstration that stable integration of a construct expressing Cas9 in the germline can increase mutation and integration efficiencies; application of germline Cas9 expression in *Ae. aegypti* has increased efficiencies of targeted gene integration to \~2% \[[@B172-ijerph-14-01006]\]. These efficiencies are still low, but the advantages of the system make it the leading technology for gene-editing in mosquitoes; Cas9-mediated editing can be employed in reverse genetic studies of gene-function, which wasn't possible with transposon- and ϕC31-based transgenics and it is more adaptable, cheaper and technically more straight-forward than using ZFN and TALENs.

Cas9-mediated gene editing has also provided a platform to develop an efficient gene drive. A Cas9-based gene drive encodes the Cas9 endonuclease and an sgRNA targeting the homologous location on a chromosome that doesn't bear the construct. The Cas9 and sgRNA genes can be linked tightly with effector genes that confer either anti-pathogen or suppression phenotypes. When the Cas9 and sgRNA are expressed and target the homologous chromosome the entire cassette including the effector genes will be copied into the homologous site when the chromosome bearing the gene drive cassette is used by the cell for homology-directed repair. It has been demonstrated that at least \~17 kb of cargo can be encoded on the cassette and effectively copied during HDR \[[@B164-ijerph-14-01006]\]. Under these circumstances HDR is much more efficient than is seen during initial transformation; 90--100% of offspring contain integrations of a gene cassette indicative of repair by HDR.

The original bacterial Cas9 could potentially modify any arthropod genome, a quality that led almost immediately to the application of gene drive to multiple mosquito species and the expansion of transgenic technologies to new dipteran and non-dipterans insect species \[[@B166-ijerph-14-01006],[@B186-ijerph-14-01006],[@B187-ijerph-14-01006],[@B188-ijerph-14-01006],[@B189-ijerph-14-01006],[@B190-ijerph-14-01006],[@B191-ijerph-14-01006],[@B192-ijerph-14-01006],[@B193-ijerph-14-01006],[@B194-ijerph-14-01006],[@B195-ijerph-14-01006],[@B196-ijerph-14-01006],[@B197-ijerph-14-01006]\]. The species specificity of SIT and synthetic transgenic drives offers an advantage over less targeted vector control approaches (e.g., insecticides) in that control can be applied to a specific insect species and can avoid beneficial and neutral insect species or non-insect species. But this same quality means that an individual genetic approach will have to be employed for every target species. This can be a major limitation for mosquitoes, if the technology to develop individual gene drives is not efficient since, in many regions there are several mosquito species that are recognized as important vectors, many more that may be under-recognized vectors and because *Anopheles* species exist as morphologically indistinguishable, but genetically distinct cryptic species \[[@B198-ijerph-14-01006],[@B199-ijerph-14-01006],[@B200-ijerph-14-01006],[@B201-ijerph-14-01006]\]. Cas9 gene-editing (and similar emerging platforms) offer a technically realistic means to target several species engineered genetically to serve either modification or suppression strategies that can be integrated with other approaches to help address a need for more vector control tools in light of evolving resistance to many of our current approaches ([Figure 1](#ijerph-14-01006-f001){ref-type="fig"}).

3. A Dramatic Shift in the Application of Genetic Approaches to Mosquito and Mosquito-Transmitted Disease Control: Perspectives on the Future {#sec3-ijerph-14-01006}
=============================================================================================================================================

> "*Clearly, the technology described here is not to be used lightly. Given the suffering caused by some species, neither is it obviously one to be ignored.*"
>
> ---Austin Burt \[
>
> 75
>
> \].

The application of Cas9 to gene drive represents a second major shift in the field of vector genetics for disease control. It is now technically straight-forward to develop any number of genetic strategies and so add a substantial new subset of tools to vector control efforts ([Figure 1](#ijerph-14-01006-f001){ref-type="fig"}), so how do we use CRISPR/Cas9 and similar technologies for gene editing and gene drive given the enormous potential to alleviate human suffering? Challenges will arise in efforts to implement molecular techniques developed in the lab to field releases. We will do well to heed the lessons learned by previous work and to carefully consider the challenges that have emerged alongside the introduction of efficient, site-specific gene-editing.

3.1. Long-Standing Considerations {#sec3dot1-ijerph-14-01006}
---------------------------------

### 3.1.1. Early Successes Provide Templates for Predicting Success {#sec3dot1dot1-ijerph-14-01006}

Sterile insect technique and genetics-based control tools were first tested in mosquito populations in the 1960s. Initial field trials with *An. quadrimaculatus*, *Ae. aegypti* and *Cx. pipiens fatigans* failed to control test populations and it was only when chemosterilization with the chemical agent thiotepa replaced radiation as the primary means to sterilize males, that the switch in methods led to the first successful mosquito SIT program \[[@B202-ijerph-14-01006],[@B203-ijerph-14-01006],[@B204-ijerph-14-01006],[@B205-ijerph-14-01006],[@B206-ijerph-14-01006]\]. Chemosterilized *Cx. pipiens* eliminated the native population after 10 weeks of sterile male releases in Seahorse Key (FL, USA) \[[@B202-ijerph-14-01006]\]. These early successes and failures suggest that vector control tools that look promising in the laboratory don't always translate into promising outcomes in the field. Better means to predict field success are needed. Compared to laboratory studies, wild populations may be more likely to experience density-dependence and the effect of released sterile males could be reduced by migrating inseminated females from outside of the release area \[[@B203-ijerph-14-01006]\]. Early modeling efforts to predict the success of sterile male release programs suggested that even modest immigration of mosquitoes into a release area could doom a population suppression program to failure, leading Asman and others to conclude that "with immigration, eradication is not possible and continued sterile male release would be required in order to maintain tolerable low levels of the pest" \[[@B200-ijerph-14-01006]\]. In contrast, population modification strategies are likely more resilient to immigration of mosquito populations into and out of a release area and the replacement rate can be predicted by the fitness differences between the released mosquito and wild-type \[[@B203-ijerph-14-01006]\]. Although gene drive mechanisms exhibit non-Mendelian inheritance patterns and can likely tolerate more fitness costs than mechanisms with Mendelian inheritance, fitness still plays an important role in predicting success of population suppression or modification \[[@B139-ijerph-14-01006],[@B207-ijerph-14-01006],[@B208-ijerph-14-01006],[@B209-ijerph-14-01006]\].

Not surprisingly, we can still largely depend on a 50-year-old framework for assessing the potential of a mechanism prior to implementation, considerations for release and evaluating the outcomes. Perhaps the most important appeal to be made of researchers is to aggressively collect data. Recommendations that data be collected on the disease and vector biology, environment and population dynamics of the targeted insect, the fitness and thus competitiveness of released strains compared to wild populations, and the rearing and handling requirements strategy are in every milestone assessment review on the topic of genetic control of insects and cannot be underemphasized in the context of gene drive \[[@B20-ijerph-14-01006],[@B23-ijerph-14-01006],[@B53-ijerph-14-01006],[@B210-ijerph-14-01006],[@B211-ijerph-14-01006],[@B212-ijerph-14-01006],[@B213-ijerph-14-01006],[@B214-ijerph-14-01006]\]. The drive rate, tolerable fitness reductions, tolerable levels of drive-resistance, and optimal distribution and timing for successful release need to be modeled with field-relevant parameters to predict success of a release program. Ongoing surveillance data will be critical to interpreting the success of release strategies, identifying useful modifications to an approach including replacement of a drive-strategy, and determining whether a reversal of the drive is necessary.

### 3.1.2. Identify and Measure Appropriate Proxies for Assessing the Fitness of a Treatment Strain {#sec3dot1dot2-ijerph-14-01006}

Understanding the contribution of the fitness of specialized mosquitoes relative to the wild target population is pivotal to predicting the success of a genetic strategy for vector control, since the transfer of genetic material from released mosquitoes to offspring in the wild depends on competition with wild mosquitoes for resources and mating. Most genetics-based control strategies are first tested in cage trials, where population modification or suppression can be observed under different ratios of genetically modified individuals to unaltered individuals, and under conditions where life history traits can be carefully measured and environmental variables such as resource availability, temperature and humidity can be controlled. Standard laboratory assessments prior to field release of a genetically altered insect include measuring mating competitiveness, but rarely are more holistic measurements of fitness captured \[[@B214-ijerph-14-01006],[@B215-ijerph-14-01006]\]. While unsuccessful cage trials can signal when a technology will likely fail in the field, a successful cage trial does not always translate into field success. Even within the laboratory, trial-to-trial variability is sometimes only explained by looking at fitness parameters across the insect lifespan. In 1973, trials with *Drosophila* testing population replacement of a laboratory population with modified strains that had compound autosomes, demonstrated that predicting successful versus unsuccessful strains required more holistic estimates of fitness than egg hatch rate alone \[[@B211-ijerph-14-01006]\]. Similarly, failed field releases of irradiated *Ae. aegypti* males for population suppression in Pensacola, Florida was later attributed to poor survival in the pupal stage, again highlighting the need for thorough evaluation of the consequences of sterilization or genetic-alteration on mosquito fitness across life stages prior to release \[[@B205-ijerph-14-01006],[@B214-ijerph-14-01006]\]. Failed release programs have the consequence of not only wasting resources, but threatening the success of future programs by creating public mistrust or donor reluctance in supporting these types of technologies.

Evaluating fitness costs of gene drive technologies involves estimating fitness by measuring life history traits across the mosquito life cycle, or tracking allele frequencies in populations over time. Both approaches are difficult. The best fitness proxies to estimate mosquito fitness have not been clearly identified, but life history theory suggests that fitness is more sensitive to life history traits that describe early life events such as egg hatching rates and larval survival than to late-life traits such as adult survival. Juvenile traits should therefore be prioritized as the most predictive life history traits in estimating fitness when evaluating the potential for a gene drive to spread. Once spread, the impact of the drive mechanism on mosquito fitness can be used to understand potential evolutionary responses of mosquitoes to the drive mechanism and co-evolutionary changes in the parasite populations they spread. Even a drive mechanism that comes with minimal fitness costs to the mosquito could fail to reduce disease incidence or prevalence if it affects vector competence while only minimally changing vectorial capacity \[[@B216-ijerph-14-01006]\]. Understanding both vector and parasite fitness traits and their potential to evolve in response to genetics-based technologies should be understood prior to releasing these technologies into the field. A combination of computer simulations, laboratory studies that evaluate fitness parameters across the mosquito lifespan, an understanding of local ecology, and ongoing surveillance after release programs begin will be important to a robust deployment of genetics-based control.

### 3.1.3. The Importance of Modeling {#sec3dot1dot3-ijerph-14-01006}

Modeling allows us to integrate large amounts of collected data and logically draw conclusions that are not always intuitive to predict success or failure of a release program. This is especially important for identifying the ability of a genetic approach to work across different mosquito-pathogen systems. Models demonstrating the potential of certain gene drive strategies have given us reason for both optimism and concern \[[@B210-ijerph-14-01006],[@B217-ijerph-14-01006],[@B218-ijerph-14-01006],[@B219-ijerph-14-01006],[@B220-ijerph-14-01006]\]. Working from a perspective that different drive approaches will be optimal for different applications, Eckhoff modeled the vector and drive mosquito population outcome using different gene drive strategies in specific locations (Tanzania and Garki) with varying homing rates and fitness reductions \[[@B217-ijerph-14-01006]\]. Optimism for gene drive is supported by their suggestions that even the most challenging situations stand to benefit from a gene drive strategy if a certain set of qualifications are attained. With very high homing rates demonstrated for recently developed drives, it is realistic that such qualifications can be met, even with a fitness reduction in transgenic drive insects \[[@B217-ijerph-14-01006]\]. Eckhoff identified major unknowns in their studied locations including aestivation behavior of vectors and movement of males, and differences between such behaviors between vector and transgenic drive insects that would inform the success of a release program. Since multiple vectors and species complexes contribute differently to disease transmission, modeling will also serve to inform which species are most important to target in a given region in order to have the greatest impact, which will in turn inform the lab-based efforts to develop appropriate drives for each species.

### 3.1.4. Which Tools, Where {#sec3dot1dot4-ijerph-14-01006}

The complexity of vector-borne disease transmission dynamics across the globe means that a successful global eradication strategy, a current goal for both malaria and lymphatic filariasis, will require a diverse tool set and region-specific vector control application of a subset of those tools \[[@B221-ijerph-14-01006],[@B222-ijerph-14-01006],[@B223-ijerph-14-01006]\]. The current toolkit includes insecticide-treated bed nets (LLINs), anti-malarial and anti-filarial drugs, a yellow fever virus vaccine, indoor residual spraying, structural modifications to housing (improved housing material, screens, eave-tubes), larval habitat treatment, *Wolbachia*-based gene drive (Eliminate Dengue), *Wolbachia-*based population suppression (MosquitoMate and Verily), and a transgenic RIDL strain (release of individuals carrying a dominant lethal, flightless female strain OX513A) ([Figure 1](#ijerph-14-01006-f001){ref-type="fig"}). This toolkit is growing to soon include additional arbovirus and malaria vaccines. Some tools, specifically those dependent on pyrethroids and other insecticides, are becoming less useful due to growing insecticide-resistance \[[@B88-ijerph-14-01006],[@B224-ijerph-14-01006],[@B225-ijerph-14-01006],[@B226-ijerph-14-01006],[@B227-ijerph-14-01006],[@B228-ijerph-14-01006]\]. The variety of genetic tools currently in development since the advance in genetic technologies can target many aspects of mosquito and pathogen life cycles and have real potential to improve this toolkit ([Figure 1](#ijerph-14-01006-f001){ref-type="fig"}). Theoretical analyses that have evaluated added benefits from combining vector control tools have suggested that some combinations are more effective than others. For example, LLINs in combination with larvicides are predicted to result in greater reductions in mosquito abundance than the use of LLINs with IRS or LLINs alone \[[@B229-ijerph-14-01006]\]. In practice, combined use of BT with LLINs has reduced the incidence of malaria infection to a greater extent than LLINs alone in western Kenya \[[@B230-ijerph-14-01006]\]. Similar analyses and field experiments should be done to evaluate how genetic technologies will work in combination with other existing vector control measures; the inclusion of newly available and/or underutilized technologies in these analyses will greatly benefit our ability to achieve local elimination and global eradication goals. Specifically, identifying the vector control approach or approaches that most greatly impact disease transmission will provide useful direction in releasing specialized mosquito strains (transgenic or *Wolbachia-*infected) in areas where they best complement current approaches and have maximal effect in reducing disease.

3.2. New Considerations {#sec3dot2-ijerph-14-01006}
-----------------------

### 3.2.1. Gene drive Resistance {#sec3dot2dot1-ijerph-14-01006}

New considerations regarding the potential for drive-resistance have arisen from the molecular mechanisms of site-specific endonucleases. Homing endonucleases- and Cas9-based gene drives generate resistance because the double-stranded break necessary for HDR-mediated insertion of the drive construct is occasionally repaired by using non-homologous end joining (NHEJ) instead. Repair by NHEJ often causes insertions or deletions in the target site, rendering it impervious to future targeting by the endonuclease. When HEGs were first proposed as a site-specific gene drive, it was recognized that variation and mutation in the sequence of the target site would provide a source of resistance to the drive, but also that strategic drive design would likely lead to successful gene drive \[[@B75-ijerph-14-01006],[@B231-ijerph-14-01006]\]. Recent modeling of sources of sequence variation, both naturally occurring and induced by the drive mechanism itself, suggest that resistance will almost certainly emerge to a simple one-target Cas9-based gene drive \[[@B219-ijerph-14-01006]\]. Even modest rates of NHEJ are likely to impact the effectiveness of gene drive strategy \[[@B217-ijerph-14-01006],[@B219-ijerph-14-01006],[@B232-ijerph-14-01006],[@B233-ijerph-14-01006]\]; in order for a gene drive to be successful, the emergence of resistance to the drive must be at least five orders of magnitude lower than what have been observed in recently demonstrated drives \[[@B163-ijerph-14-01006],[@B164-ijerph-14-01006],[@B165-ijerph-14-01006],[@B179-ijerph-14-01006]\]. Gene drives based on site-specific endonucleases rely on the repair mechanism of the organism, so that it may be difficult to engineer a gene drive scenario that manipulates that host-biology such that HDR is favored over NHEJ to such an extent as to provide orders of magnitude fewer occurrences of resistant alleles. Approaches to mitigate the effects of gene drive resistance have been suggested, including targeting multiple sites for disruption, targeting highly conserved sites or sites where indels caused by NHEJ would cause lethality or infertility, and altering the promotors and genomic targets of a gene drive. Recent investigations into these suggestions provide optimism that shortcomings of single-target Cas9-based gene drives can be overcome in future gene drive designs \[[@B179-ijerph-14-01006],[@B232-ijerph-14-01006],[@B233-ijerph-14-01006],[@B234-ijerph-14-01006],[@B235-ijerph-14-01006]\]. Multiplexed gene drives are expected to substantially decrease the likelihood of gene drive resistant alleles emerging using only a few additional targets \[[@B232-ijerph-14-01006]\]. Feasible ways to multiplex Cas9-based gene drives have been demonstrated using post-transcriptional processing of several sgRNAs expressed from a single promoter, but these have not yet been applied to mosquitoes \[[@B232-ijerph-14-01006],[@B234-ijerph-14-01006],[@B236-ijerph-14-01006],[@B237-ijerph-14-01006],[@B238-ijerph-14-01006]\].

Both *Wolbachia*-based and transgene-based approaches to vector control, including MEDEA- or transposon-based drives and transgenic population suppression strains, face the risk of becoming inert due to effector inactivation. Some data suggests that mosquito immune responses to *Wolbachia* prime the mosquito against viruses, like dengue, but this response could weaken over time as *w*Mel and *Ae. aegypti* co-evolve, dampening refractoriness to RNA viruses \[[@B239-ijerph-14-01006],[@B240-ijerph-14-01006]\]. *Wolbachia-*based population modification targets a rapidly evolving virus, which could change to avoid the mechanism causing refractoriness in *Wolbachia*-infected *Ae. aegypti*. Because the biology of these interactions is largely unknown, it is prudent to closely monitor the refractoriness of mosquito populations that have been modified with *w*Mel infection. Concern has been raised that *Ae. albopictus* populations targeted for suppression using *Wolbachia* cytoplasmic incompatibility phenotypes could become resistant to the suppression mechanism, derived from demonstrations that mosquitoes that have low abundance of the natural strains of *Wolbachia* are not completely sterile when they mate with *w*Pip infected mosquitoes \[[@B241-ijerph-14-01006]\]. Such mosquitoes do exist in the targeted populations and depending on how many *w*Pip-infected females escape sexing during rearing, *w*Pip may become established in the wild population, rendering the strategy useless \[[@B241-ijerph-14-01006]\]. However, recent developments in sex separation techniques will likely improve the proportion of females released to address this issue \[[@B226-ijerph-14-01006]\]. Transgenes and transgenic gene drives could face a different type of inactivation. Similarly to *Wolbachia*, pathogen blocking could become ineffective because of pathogen evolution. Transgenic approaches have an advantage over *Wolbachia* in this case because the biology of pathogen blocking is known and encoding numerous targets for the pathogen can reduce the development of pathogen resistance to products of the transgenic construct. Alternatively, a transgenic drive mechanism could become unlinked from the effector genes, so that the drive continues, but the pathogen blocking alleles could be lost from the population; this can be mitigated by thoughtful arrangements of the drive and effector components of a synthetic construct such that the drive becomes inactivated if the construct is disrupted by recombination \[[@B70-ijerph-14-01006]\]. Further, we know that many organisms inactivate selfish genetic elements using the piRNA pathway. While this has not been examined in mosquito transgenic lines the component of these pathways do exist in mosquitoes \[[@B242-ijerph-14-01006],[@B243-ijerph-14-01006],[@B244-ijerph-14-01006]\] and examples of transgenic constructs becoming piRNA producers with inhibited gene expression exist in Silkworm cell lines and in *Drosophila* \[[@B245-ijerph-14-01006],[@B246-ijerph-14-01006],[@B247-ijerph-14-01006],[@B248-ijerph-14-01006],[@B249-ijerph-14-01006],[@B250-ijerph-14-01006]\]. We appeal to the broader vector biology field to study the underlying processes of the *Wolbachia*-mediated virus refractoriness and transgene inactivation and at the risk of being redundant are hopeful that these biological processes will be easier to probe with the application of reverse-genetics by site-specific gene editing.

### 3.2.2. Off-Target Effects of the Cas9/sgRNA Complex {#sec3dot2dot2-ijerph-14-01006}

Potential off-target activity of the Cas9 due to homology between sgRNAs and non-target sites in the genome presents an interesting challenge for Cas9-based gene drive. Off-target effects are not a Cas9 specific concern: RNA interference (RNAi) methods utilizing the micro- and small interfering-RNA (miRNA and siRNA respectively) also rely on ribonucleoprotein activity and are prone to inhibiting transcripts other than the intended target. An understanding of ribonucleoprotein complex characteristics and homology-based cleavage requirements have enabled researchers to faithfully use RNAi in genetics, but similar considerations for optimizing sgRNAs for use with Cas9 have not been completely teased out. To date unintended mutations induced by Cas9 have been difficult to detect and quantify. In general, genome sites with potential for off-target cleavage by a given sgRNA/Cas9 complex can be predicted using computational algorithms and then probed for mutations by PCR-based assays or larger units of genetic material (DNA or cDNA) can be deep-sequenced for indels or single nucleotide polymorphisms (SNPs) \[[@B251-ijerph-14-01006],[@B252-ijerph-14-01006]\]. However, Cas9-induced off-target SNPs can be difficult to quantify accurately without a robust dataset documenting all SNPS already existing in a population to reduce false identification of off-target mutations. In mosquitoes, as in other organisms, efforts have not led to any detectable, off-target Cas9-induced mutations but a thorough analysis in mosquitoes has not yet been reported. Efforts underway by the *An. gambiae* 1000 genomes project to build a genome data set from wild-caught mosquitoes will aid in detecting potential off-target effects \[[@B159-ijerph-14-01006],[@B191-ijerph-14-01006],[@B253-ijerph-14-01006],[@B254-ijerph-14-01006],[@B255-ijerph-14-01006]\]. Other methods for detecting off-target activity of Cas9 include assays for identification of double stranded breaks or genome binding of a Cas9/sgRNA complex with inactivated nuclease activity, though these methods have not yet been used in mosquitoes \[[@B256-ijerph-14-01006],[@B257-ijerph-14-01006],[@B258-ijerph-14-01006]\]. Rare unintended mutations have been identified in mouse studies and notably, off-targeting in in vitro studies has been more highly reported, likely because many more genomes exposed to the Cas9/sgRNA complex are sequenced, giving the researchers a higher power to detect very rare off-target mutations \[[@B252-ijerph-14-01006],[@B257-ijerph-14-01006],[@B258-ijerph-14-01006],[@B259-ijerph-14-01006],[@B260-ijerph-14-01006],[@B261-ijerph-14-01006]\].

The impact of unwanted mutation for gene drive applications is higher than for in-lab gene editing since mutations arising after release of a gene drive into a population have the potential to persist. In the case of a gene drive that is self-limiting, like those proposed for population suppression, the mistakes would be eliminated with the population itself. Off-target mutations are another source of potential fitness effects in gene drive mosquitoes designed for population modification strategies. These considerations fall squarely under the category of "unintended consequences" of the release of transgenic organisms with a drive mechanism, a common topic in academic, political and lay discussions on the utility and ethical considerations of gene drive. It thus behooves us to be able to quantify and model the possibility of introduction of mutations derived by off-targeting of the drive components into the target mosquito populations. This will require a thorough sampling of the genomes that exist in the target population and continued sampling of genomes after release of gene drive laden mosquitoes with the specific intention of detecting new, unintended mutations.

It may be that such quantification will provide an increased confidence in the Cas9-based gene drive strategies already in development. However, should prudence require increased specificity in nuclease activity, approaches to increase specificity and efficiency of the RNA-guided endonuclease have already been demonstrated to be effective, including truncation of the sgRNA, the use of Cas9 nickases (a Cas9 mutant that only cuts a single DNA strand) with offset target sites, highly-specific Cas9 mutants like eSpCas9 and SpCasp-HF1 and alternate RNA-guided nucleases like Cpf1 that create sticky double stranded breaks \[[@B251-ijerph-14-01006],[@B257-ijerph-14-01006],[@B262-ijerph-14-01006],[@B263-ijerph-14-01006],[@B264-ijerph-14-01006],[@B265-ijerph-14-01006],[@B266-ijerph-14-01006],[@B267-ijerph-14-01006]\]. Algorithms for sgRNA design are updated regularly to incorporate both new knowledge on off-target effects and increasing number of genomes in order to generate specific and efficient sgRNAs \[[@B268-ijerph-14-01006],[@B269-ijerph-14-01006]\]. The measuring and addressing off-target effects and their potential impacts on gene drive strategies are areas that will continue to require a substantial amount of attention.

### 3.3.3. Containing an Efficient Gene drive {#sec3dot3dot3-ijerph-14-01006}

The likelihood that a gene drive cassette would persist in the environment in the case of accidental release from lab containment, a test site or a rearing facility has been modelled between different drive mechanisms and depends variably on the number of mosquitoes released and the efficiency of the drive \[[@B270-ijerph-14-01006]\]. The novelty of the levels of efficiency observed for recent applications of CRISPR/Cas9 biology requires a re-consideration of the potential to control the activity of the gene drive both during experimentation in the lab with the possibility of accidental release and once intentionally released into the wild for disease control applications. A high level of care when working with gene drive constructs has been echoed through the field as essential to the ethical development of the CRISPR/Cas9-based technology for all potential applications \[[@B235-ijerph-14-01006],[@B271-ijerph-14-01006],[@B272-ijerph-14-01006],[@B273-ijerph-14-01006]\]. In addition to gene drive containment recommendations, several mechanisms to reverse a drive following the intentional releases are being developed. These strategies are particularly relevant for population modification strategies, since population suppression strategies are inherently limited. The Cas9/sgRNA complex and HEGs have both been proposed as the basis of both reversal mechanisms including designs for synthetic constructs driven *in trans* by another construct, even in several iterations (called "daisy chains"), in order to limit the spread of independent self-driving constructs in the case of an accidental release \[[@B75-ijerph-14-01006],[@B152-ijerph-14-01006],[@B274-ijerph-14-01006],[@B275-ijerph-14-01006]\]. Such systems have been demonstrated in yeast and modelled to provide a robust and containable drive mechanism \[[@B275-ijerph-14-01006]\].

### 3.3.4. Globalization {#sec3dot3dot4-ijerph-14-01006}

Globalization impacts vector control strategies in two foreseeable ways. First, mosquitoes released for population suppression and replacement efforts disperse without regard to political boundaries. In an age of increasing global movement by humans, dispersal of genetically-altered mosquitoes outside of intended release zones is inevitable. Genetics-based control efforts will have to evaluate how to contain genetically-altered mosquitoes in population replacement programs, and deploy intensive surveillance for population suppression efforts to avoid migration into and out of the release zones when there are concerns over unintended consequences. For suppression programs, migration into a release area or an area that has already achieved local elimination could result in repopulation of the mosquitoes we were trying to control. For population modification strategies, dispersal of released mosquitoes outside of intended areas could create political tensions with bordering countries that may not have approved the technology. Improved molecular tools, buffer zones with alternative control strategies near political borders, remote sensing of mosquitoes with improved traps or acoustic identification technology \[[@B276-ijerph-14-01006]\], or citizen scientist campaigns to detect or sample local mosquitoes could all contribute to more effective and contained vector control campaigns. To address concerns of population replacement campaigns resulting in new populations susceptible to new diseases, improved xenosurveillance and future efforts to make surveillance faster and easier will likely make any unintended consequences quickly detectable and easier to address \[[@B277-ijerph-14-01006]\].

Second, rapid globalized human communication is a novel tool for complex vector management approaches and can be leveraged to integrate the various levels of information that will influence the planning, implementation, assessment and adjustment of a strategy, including information on the population structures of target regions, current release efforts, surveillance of specialized mosquito strains following release and resulting epidemiological changes. Many release strategies are being tested around the world, with only minimal available information in these categories. Eliminate Dengue has a map indicating sites where *w*Mel-infected mosquitoes are being released with links to the progress made in those areas. Oxitec and MosquitoMate have information about ongoing releases of transgenic line OX513A *Ae. aegypti* and *w*Pip-infected *Ae. albopictus* respectively, but without interactive maps \[[@B227-ijerph-14-01006],[@B278-ijerph-14-01006]\]. Verily Life Sciences will begin releases of *w*AlbB-infected *Ae. aegypti* in California and Queensland soon. Releases of sterile *An. arabiensis* are ongoing in South Africa and Sudan \[[@B279-ijerph-14-01006],[@B280-ijerph-14-01006]\]. Test releases of sterilized *Ae. aegypti* have been conducted in Italy, Indonesia, Mauritius and China and, *Wolbachia*-laden *An. polynisiensis* and *Cx. pipiens quinquefasciatus* are being tested in for cytoplasmic incompatibility in French Polynesia for lymphatic filiariasis control and La Reunion for arbovirus control, respectively \[[@B281-ijerph-14-01006]\]. Optimally, data collected in concurrence with these releases could be integrated into a single framework. VectorBase.org is particularly well poised to undertake these efforts; vector genetic information contributed by scientists is integrated and openly available to others. Mosquito insecticide resistance is being collected in this database, is accessible also as interactive map, and is being expanded to include additional phenotypes of existing mosquito populations \[[@B282-ijerph-14-01006]\]. Further expansion including transgene information and *Wolbachia-*infection status overlaid with epidemiological data such as those presented by internet disease surveillance sites like healthmap.org and the Malaria Atlas Project will support release and data openness goals \[[@B283-ijerph-14-01006],[@B284-ijerph-14-01006]\]. Internet-based platforms for the integration of population and epidemiological data and ongoing releases could promote the sharing of information between scientists, practitioners and policy makers and encourage an atmosphere of participation and openness among lay people.

4. Conclusions {#sec4-ijerph-14-01006}
==============

The technical innovations that have led to efficient gene drives have caused a shift of focus in the field of vector biology from tool development that might allow us to use genetics to combat disease vectors, to considerations, experimentation, and modeling of what it will look like to use these approaches effectively. Many considerations for successful implementation of genetic tools for vector control have been on the minds of biologists for more than 60 years and some have arisen from the specific tools that we intend to use. The breadth of molecular mechanisms and the adaptability of genetic engineering afforded by the CRISPR/Cas9 and related systems means that we have many avenues to pursue the engineering of strains that address the complexities of different control strategies and that can be integrated with existing structural, chemical and biocontrol tools for successful vector-borne disease programs. In light of a need for unique sets of tools under different environmental, vector and pathogen circumstances, we should not merely undertake to prove superiority of the technology our own group is developing, but instead to provide quality analyses of the purposes of and the circumstances under which our tools will and will not be useful, so that a community adding a genetic component to their disease control strategy can make informed decisions on what will have the greatest epidemiological impact.
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![Genetic approaches to vector-borne disease offer a substantial complement to the existing tool-set. A scheme illustrating the contribution of specialized mosquito strains, including both transgenic and *Wolbachia-*infected mosquitoes, to vector control. Each strategy is categorized on the right as modification or suppression, whether the strategy can utilize Cas9 gene-editing or gene drives are indicated with a star. Whether a specific mosquito life-cycle stage or the pathogen life-cycle are targeted is indicated by a red line. The center schematic is a stylistic representation of vector-borne pathogens and is included to illustrate where specialized mosquito strains can be used to inhibit pathogen development in the mosquito. A summary of existing, non-genetic tools is to the left of the schematic. RIDL: release of insects carrying a dominant lethal, SIT: sterile insect technique, CI: cytoplasmic incompatibility, LLIN: long-lasting insecticide treated nets, IRS: indoor residual spraying, ATSB: attractive toxic sugar baits.](ijerph-14-01006-g001){#ijerph-14-01006-f001}
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###### 

Comparison of genetic techniques and their application to mosquito genetic manipulation and gene drive.

                                            Genetic Techniques                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  ----------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Origin and biological basis**           Transposable elements discovered in the 1950\'s in maize, specifically DNA (type II) transposons.                                                                                                                                                                                                                                                                  ϕC31 transposase-mediated integration of bacteriophage DNA into bacterial genomes                                             Group I introns discovered prior to 1970 in yeast that show higher than Mendelian inheritance proportions                                                                                          Zinc-binding domain from transcription factors for DNA recognition, FokI endonuclease for DNA cleavage, first fused for site-specific DNA cleavage in 1996                    TALE proteins discovered in *Xanthomonas* species were decoded in 2009 and conjugated to FokI endonuclease                                            *S. pyogenes* CRISPR/Cas9 biology for destruction and memory of parasitic nucleic acid
  **Initial use for genome modification**   1982 *(D. melanogaster)*                                                                                                                                                                                                                                                                                                                                           1982 (*S. pyogenes*)                                                                                                          1998 (*E.coli*)                                                                                                                                                                                    2001 (*Xenopus laevis*)                                                                                                                                                       2010 (S. *cerevisiae*)                                                                                                                                2012 (Human cell lines)
  **Year used in mosquitoes**               1998                                                                                                                                                                                                                                                                                                                                                               2006                                                                                                                          2011                                                                                                                                                                                               2013                                                                                                                                                                          2013                                                                                                                                                  2015
  **Mechanism**                             Transposase mediated transfer of DNA between ITRs either from a plasmid into the mosquito genome (transformation) or from one place in a genome to another                                                                                                                                                                                                         ϕC31 integrase mediates integration of a plasmid bearing an attB site into a complementary attP site on the mosquito genome   HEG encoded endonuclease recognizes and cleaves genomic DNA such that a gene cassette can be integrated by cell HDR machinery                                                                      Pairs of zinc-finger domains recognize and bind a sequence of nucleotide triplets, each endonuclease cuts the DNA backbone, together creating a double-stranded break         Pairs of TALE domains recognize and bind a sequence of nucleotides, each endonuclease cuts DNA backbone, together creating a double-stranded break    Cas9 protein bound to a sgRNA through scaffold sequence on the sgRNA recognizes a genomic sequence that is complementary to \~20 nucleotides on the sgRNA
  **Mutation efficiency \***                NA                                                                                                                                                                                                                                                                                                                                                                 NA                                                                                                                            1--9%                                                                                                                                                                                              \<7%                                                                                                                                                                          \<16%                                                                                                                                                 \>90%
  **Transformation efficiency \***          \~2%                                                                                                                                                                                                                                                                                                                                                               10--18%                                                                                                                       \<1%                                                                                                                                                                                               \<6%                                                                                                                                                                          \~2%                                                                                                                                                  \~2%
  **Gene drive \***                         Potentially                                                                                                                                                                                                                                                                                                                                                        No                                                                                                                            Yes                                                                                                                                                                                                No                                                                                                                                                                            No                                                                                                                                                    Yes
  **Drive efficiency**                      \<\<0.05%                                                                                                                                                                                                                                                                                                                                                          NA                                                                                                                            56%                                                                                                                                                                                                NA                                                                                                                                                                            NA                                                                                                                                                    90--100%
  **Benefits**                              First available transformation technique in mosquitoes, some natural transposons are extremely efficient gene drives.                                                                                                                                                                                                                                              Insertion into a known site                                                                                                   Insertion into a known site, high efficiency, recognition of sites on X-chromosome only in *An. gambiae*                                                                                           Site-specific editing. Double stranded cuts allowed targeted mutagenesis-first gene editing technique for reverse genetics                                                    Site-specific editing, efficient mutagenesis, TALEN expression plasmids could be cloned in-house.                                                     Site-specific, easily re-engineered, adaptable to different species. Highly efficient for mutagenesis and as a drive.
  **Drawbacks**                             Random insertion, low transformation efficiency, very low mobility of synthetic transposon once integrated into the genome                                                                                                                                                                                                                                         Requires pre-insertion of the attP site using transposition                                                                   Requires pre-existing target-sites, re-engineering of the HEG, or transgenesis for insertion of target sites. Drive mechanism generates drive-resistant alleles.                                   Expensive, requires modular protein engineering, some codons were not recognized by any zinc-fingers, requires in vitro optimization                                          Requires protein engineering, timing: introduced just before Cas9 was demonstrated for gene-editing                                                   Drive mechanism generates drive-resistant alleles
  **References**                            \[[@B40-ijerph-14-01006],[@B42-ijerph-14-01006],[@B43-ijerph-14-01006],[@B44-ijerph-14-01006],[@B45-ijerph-14-01006],[@B46-ijerph-14-01006],[@B47-ijerph-14-01006],[@B48-ijerph-14-01006],[@B49-ijerph-14-01006],[@B50-ijerph-14-01006],[@B57-ijerph-14-01006],[@B173-ijerph-14-01006],[@B174-ijerph-14-01006],[@B175-ijerph-14-01006],[@B176-ijerph-14-01006]\]   \[[@B50-ijerph-14-01006],[@B132-ijerph-14-01006],[@B142-ijerph-14-01006],[@B143-ijerph-14-01006],[@B177-ijerph-14-01006]\]    \[[@B73-ijerph-14-01006],[@B75-ijerph-14-01006],[@B79-ijerph-14-01006],[@B152-ijerph-14-01006],[@B178-ijerph-14-01006],[@B179-ijerph-14-01006],[@B180-ijerph-14-01006],[@B181-ijerph-14-01006]\]   \[[@B144-ijerph-14-01006],[@B145-ijerph-14-01006],[@B146-ijerph-14-01006],[@B147-ijerph-14-01006],[@B154-ijerph-14-01006],[@B182-ijerph-14-01006],[@B183-ijerph-14-01006]\]   \[[@B148-ijerph-14-01006],[@B150-ijerph-14-01006],[@B153-ijerph-14-01006],[@B159-ijerph-14-01006],[@B184-ijerph-14-01006],[@B185-ijerph-14-01006]\]   \[[@B156-ijerph-14-01006],[@B159-ijerph-14-01006],[@B160-ijerph-14-01006],[@B161-ijerph-14-01006],[@B162-ijerph-14-01006],[@B163-ijerph-14-01006],[@B164-ijerph-14-01006],[@B166-ijerph-14-01006],[@B167-ijerph-14-01006],[@B169-ijerph-14-01006],[@B170-ijerph-14-01006],[@B171-ijerph-14-01006],[@B172-ijerph-14-01006]\]

Note: **\*** Mutation and transformation efficiency are represented slightly differently in different mosquito studies, but for a rough comparison, mutation efficiency here represents the percentage of G~1~ offspring with a deletion (not unique deletion events) and transformation efficiency is the percentage of individual surviving G~0~ that produced transgenic offspring. Gene drive efficiency is represented by the gene-conversion rate or the proportion of wild-type alleles converted to drive alleles. HEG: homing endonuclease gene; ZFN: zinc-finger nuclease; TALEN: transcription activator-like effector nuclease, ITR: inverted terminal repeat, HDR: homology-directed repair.
